Published in Ann Surg Oncol on July 01, 2000
Breast cancer in elderly women (≥ 80 years): variation in standard of care? J Surg Oncol (2010) 0.89
The path to recurrence is paved with good intentions. Ann Surg Oncol (2000) 0.75
Obesity in the mouse model of pro-opiomelanocortin deficiency responds to peripheral melanocortin. Nat Med (1999) 4.78
Association of human herpes virus 6 (HHV-6) with multiple sclerosis: increased IgM response to HHV-6 early antigen and detection of serum HHV-6 DNA. Nat Med (1997) 3.65
Validation of the accuracy of intraoperative lymphatic mapping and sentinel lymphadenectomy for early-stage melanoma: a multicenter trial. Multicenter Selective Lymphadenectomy Trial Group. Ann Surg (1999) 3.56
Identification of a photoreceptor-specific mRNA encoded by the gene responsible for retinal degeneration slow (rds). Nature (1989) 3.31
Prospective observational study of sentinel lymphadenectomy without further axillary dissection in patients with sentinel node-negative breast cancer. J Clin Oncol (2000) 3.13
Histopathologic validation of the sentinel lymph node hypothesis for breast carcinoma. Ann Surg (1997) 2.49
Intraoperative examination of the sentinel lymph node for breast carcinoma staging. Am J Clin Pathol (1999) 2.23
The prevalence of carcinoma in palpable vs impalpable, mammographically detected lesions. AJR Am J Roentgenol (1991) 1.91
Limitations of specific reverse-transcriptase polymerase chain reaction markers in the detection of metastases in the lymph nodes and blood of breast cancer patients. J Clin Oncol (1998) 1.90
Optimal histopathologic examination of the sentinel lymph node for breast carcinoma staging. Am J Surg Pathol (1999) 1.82
Do all patients with sentinel node metastasis from breast carcinoma need complete axillary node dissection? Ann Surg (1999) 1.77
Tumor doubling time: a selection factor for pulmonary resection of metastatic melanoma. J Surg Oncol (1998) 1.71
Pronociceptive actions of dynorphin maintain chronic neuropathic pain. J Neurosci (2001) 1.67
Long-term survival after complete resection of melanoma metastatic to the adrenal gland. Ann Surg Oncol (1999) 1.63
Role for sentinel lymph node dissection in the management of large (> or = 5 cm) invasive breast cancer. Ann Surg Oncol (2001) 1.61
Does complete resection of melanoma metastatic to solid intra-abdominal organs improve survival? Ann Surg Oncol (2001) 1.57
Sentinel-lymph-node biopsy for breast cancer--not yet the standard of care. N Engl J Med (1998) 1.54
The rationale for planned reoperation after unplanned total excision of soft-tissue sarcomas. J Clin Oncol (1985) 1.54
Accumulation of glucosylceramides in multidrug-resistant cancer cells. J Biol Chem (1996) 1.54
Ceramide glycosylation potentiates cellular multidrug resistance. FASEB J (2001) 1.53
Use of aspiration cytology and frozen section examination for management of benign and malignant thyroid nodules. Cancer (1991) 1.53
The role of sentinel lymph node biopsy in patients with differentiated thyroid carcinoma. Eur J Surg Oncol (2006) 1.51
Parotid region lymphatic mapping and sentinel lymphadenectomy for cutaneous melanoma. Ann Surg Oncol (1999) 1.47
Expression of glucosylceramide synthase, converting ceramide to glucosylceramide, confers adriamycin resistance in human breast cancer cells. J Biol Chem (1999) 1.37
Agents that reverse multidrug resistance, tamoxifen, verapamil, and cyclosporin A, block glycosphingolipid metabolism by inhibiting ceramide glycosylation in human cancer cells. J Biol Chem (1997) 1.35
Pathologic features associated with nonsentinel lymph node metastases in patients with metastatic breast carcinoma in a sentinel lymph node. Cancer (2000) 1.34
Increased HTLV-I proviral load and preferential expansion of HTLV-I Tax-specific CD8+ T cells in cerebrospinal fluid from patients with HAM/TSP. Ann Neurol (2001) 1.33
Taxol-induced ceramide generation and apoptosis in human breast cancer cells. Cancer Chemother Pharmacol (2001) 1.32
Clinical aspects of unknown primary melanoma. Ann Surg (1980) 1.27
CD8(+) T cells are an in vivo reservoir for human T-cell lymphotropic virus type I. Blood (2001) 1.27
Apigenin inhibits growth and induces G2/M arrest by modulating cyclin-CDK regulators and ERK MAP kinase activation in breast carcinoma cells. Anticancer Res (2001) 1.24
A yeast cyclophilin gene essential for lactate metabolism at high temperature. Proc Natl Acad Sci U S A (1992) 1.23
Generation of dynorphin knockout mice. Brain Res Mol Brain Res (2001) 1.22
Melanoma from unknown primary site and amelanotic melanoma. Semin Oncol (1982) 1.20
Tissue distribution and variant characterization of human herpesvirus (HHV)-6: increased prevalence of HHV-6A in patients with multiple sclerosis. J Infect Dis (2000) 1.19
Carbon dye histologically confirms the identity of sentinel lymph nodes in cutaneous melanoma. Cancer (2001) 1.19
Metastasectomy for recurrent stage IV melanoma. J Surg Oncol (1999) 1.18
Construction and screening of a genomic library specific for mouse chromosome 16. Proc Natl Acad Sci U S A (1989) 1.16
Intraoperative lymphatic mapping and sentinel lymph node dissection in breast cancer. CA Cancer J Clin (2000) 1.16
Characterization of a human follicular thyroid carcinoma cell line (UCLA RO 82 W-1). Virchows Arch B Cell Pathol Incl Mol Pathol (1989) 1.15
Occult metastases in the axillary lymph nodes of patients with breast cancer node negative by clinical and histologic examination and conventional histology. Dis Markers (1992) 1.14
Observation of the breast cancer patient with a tumor-positive sentinel node: implications of the ACOSOG Z0011 trial. Semin Surg Oncol (2001) 1.13
Sentinel lymphadenectomy in thyroid malignant neoplasms. Arch Surg (1998) 1.12
Glucosylceramide: a marker for multiple-drug resistant cancers. Anticancer Res (1998) 1.12
Mechanisms of increasing expression of a yeast gene in Escherichia coli. J Mol Biol (1980) 1.12
Detection of occult metastatic breast cancer cells in blood by a multimolecular marker assay: correlation with clinical stage of disease. Cancer Res (2001) 1.09
FOXC1 regulates the functions of human basal-like breast cancer cells by activating NF-κB signaling. Oncogene (2012) 1.08
Margin status and local recurrence after breast-conserving surgery. Arch Surg (1994) 1.08
Sentinel node metastasis in patients with breast carcinoma accurately predicts immunohistochemically detectable nonsentinel node metastasis. Ann Surg Oncol (1999) 1.07
Signal pathways involved in apigenin inhibition of growth and induction of apoptosis of human anaplastic thyroid cancer cells (ARO). Anticancer Res (2000) 1.04
Oncofetal antigen: a tumor-associated fetal antigen immunogenic in man. J Natl Cancer Inst (1979) 1.02
Growth inhibitory effects of flavonoids in human thyroid cancer cell lines. Thyroid (1999) 1.01
Toward a rational pharmacotherapy of depression. Am J Psychiatry (1980) 1.01
Uncoupling ceramide glycosylation by transfection of glucosylceramide synthase antisense reverses adriamycin resistance. J Biol Chem (2000) 1.01
Sentinel lymphadenectomy in primary breast carcinoma: an alternative to routine axillary dissection. J Surg Oncol (1996) 1.01
Detection of metastases in sentinel lymph nodes of breast cancer patients by multiple-marker RT-PCR. Int J Cancer (1998) 1.00
Impairment in motor learning of somatostatin null mutant mice. Brain Res (2001) 0.97
Pathologic examination of sentinel lymph node for breast carcinoma. World J Surg (2001) 0.97
The operative management of coexisting thyroid and parathyroid disease. Arch Surg (1990) 0.96
See one, do twenty-five, teach one: the implementation of sentinel node dissection in breast cancer. Ann Surg Oncol (1999) 0.96
Integrated control of appetite and fat metabolism by the leptin-proopiomelanocortin pathway. Proc Natl Acad Sci U S A (2001) 0.96
Practical aspects in the diagnosis and management of cystosarcoma phyllodes. Arch Surg (1988) 0.96
LDH and melanoma. Cancer (1983) 0.96
Drug combinations in the treatment of refractory depression: a review. J Clin Psychiatry (1981) 0.95
The detection of breast carcinoma micrometastases in axillary lymph nodes by means of reverse transcriptase-polymerase chain reaction. Cancer (1995) 0.95
Interferon pretreatment inhibits simian virus 40 infections by blocking the onset of early transcription. Cell (1983) 0.95
Changing metastatic patterns of osteosarcoma. Cancer (1984) 0.94
Results of ilioinguinal dissection for stage II melanoma. Ann Surg (1982) 0.94
Modification of ceramide metabolism increases cancer cell sensitivity to cytotoxics. Int J Oncol (1999) 0.93
Factors affecting sentinel node localization during preoperative breast lymphoscintigraphy. J Nucl Med (2000) 0.92
Aggregation of hydroxyapatite crystals. Biochim Biophys Acta (1976) 0.92
Lymphatic mapping and sentinel node biopsy in breast cancer. JAMA (1997) 0.92
Withdrawal symptoms during the course of imipramine therapy. J Clin Psychiatry (1980) 0.91
Evaluation of axillary lymphadenectomy without axillary drainage for patients undergoing breast-conserving therapy. Ann Surg Oncol (1998) 0.91
Biopsy method and excision volume do not affect success rate of subsequent sentinel lymph node dissection in breast cancer. Ann Surg Oncol (2000) 0.91
SDZ PSC 833, the cyclosporine A analogue and multidrug resistance modulator, activates ceramide synthesis and increases vinblastine sensitivity in drug-sensitive and drug-resistant cancer cells. Cancer Res (1999) 0.90
Multidrug resistance modulators and doxorubicin synergize to elevate ceramide levels and elicit apoptosis in drug-resistant cancer cells. Cancer (1999) 0.90
Delayed diagnosis of breast cancer as a result of normal mammograms. Arch Surg (1983) 0.89
Sentinel node biopsy in breast cancer. J Am Coll Surg (1999) 0.89
Glycosylation of ceramide potentiates cellular resistance to tumor necrosis factor-alpha-induced apoptosis. Exp Cell Res (1999) 0.88
Breast cancer presenting as renal colic. Am J Surg (1978) 0.88
Assessment of DNA methylation status in early stages of breast cancer development. Br J Cancer (2013) 0.88
Sentinel lymph node dissection for thyroid malignancy. Recent Results Cancer Res (2000) 0.88
Multiple primary melanoma. Cancer (1979) 0.88
Identifying genes within the genome: new ways for finding the needle in a haystack. Bioessays (1991) 0.87
Volume-controlled vs no/short-term drainage after axillary lymph node dissection in breast cancer surgery: a meta-analysis. Breast (2009) 0.87
One-stage repair of colovaginal fistula complicating acute diverticulitis. Am Surg (1990) 0.87